ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,177
Screening encounters
4,975
Diagnostic referrals
948
Outstanding pathways
327

Screening pathway

  1. Screening4,975Encounters
  2. Positive finding1,720Documented findings
  3. Referral948Diagnostic referrals
  4. Follow-up1,134Diagnostic visits
  5. Outcome621Resolved pathways

Stage totals use different units. Pending pathways: 327. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1002 · EXP-1002Synthetic · Site A

Full participant history through 2027-01-21, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · Invalid HPV result · Inadequate
  3. · Repeat plan · HPV DNA · Inadequate result · Scheduled for 2026-01-30
  4. · Screening · HPV DNA · Repeat · Inadequate result
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2027-02-13

Referral-time risk

No matching referral was available at this observation date.

Screened participants

4177 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1747 · Expanded synthetic participant 1747Site C — Rural Outreach Programme
EXP-1749 · Expanded synthetic participant 1749Site C — Rural Outreach Programme
EXP-1750 · Expanded synthetic participant 1750Site D — Community Engagement Programme
EXP-1751 · Expanded synthetic participant 1751Site B — Peri-Urban Access Programme
EXP-1753 · Expanded synthetic participant 1753Site C — Rural Outreach Programme
EXP-1754 · Expanded synthetic participant 1754Site B — Peri-Urban Access Programme
EXP-1755 · Expanded synthetic participant 1755Site E — Resource-Constrained Navigation Programme
EXP-1756 · Expanded synthetic participant 1756Site C — Rural Outreach Programme
EXP-1757 · Expanded synthetic participant 1757Site D — Community Engagement Programme
EXP-1758 · Expanded synthetic participant 1758Site B — Peri-Urban Access Programme
EXP-1759 · Expanded synthetic participant 1759Site C — Rural Outreach Programme
EXP-1761 · Expanded synthetic participant 1761Site E — Resource-Constrained Navigation Programme
EXP-1762 · Expanded synthetic participant 1762Site C — Rural Outreach Programme
EXP-1763 · Expanded synthetic participant 1763Site A — Urban Referral Hub
EXP-1764 · Expanded synthetic participant 1764Site A — Urban Referral Hub
EXP-1765 · Expanded synthetic participant 1765Site A — Urban Referral Hub
EXP-1767 · Expanded synthetic participant 1767Site A — Urban Referral Hub
EXP-1768 · Expanded synthetic participant 1768Site A — Urban Referral Hub
EXP-1770 · Expanded synthetic participant 1770Site C — Rural Outreach Programme
EXP-1771 · Expanded synthetic participant 1771Site B — Peri-Urban Access Programme
EXP-1773 · Expanded synthetic participant 1773Site B — Peri-Urban Access Programme
EXP-1774 · Expanded synthetic participant 1774Site D — Community Engagement Programme
EXP-1775 · Expanded synthetic participant 1775Site B — Peri-Urban Access Programme
EXP-1776 · Expanded synthetic participant 1776Site A — Urban Referral Hub
EXP-1777 · Expanded synthetic participant 1777Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1889
HPV DNA
2389
Cytology
697

Navigation activity

Barrier documented
853
Contact attempt
1382
Navigation intervention
373
Diagnostic booking
1180
Diagnostic visit
1134

Documented barriers

Contact difficulty
275
Transport difficulty
280
Appointment coordination
298

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.